Integral Diagnostics (ASX:IDX)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Integral Diagnostics.
RELATED STOCKHEAD STORIES
Health Check: Biotechs recover as peace descends on the FDA – for now
Health Check: LTR Pharma finds fast-track path to US erectile dysfunction market
Health Check: More healthcare ‘reverse ferrets’ from Trump’s razor gang
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Criterion’s small cap gems poised to star in 2025 (part one)
ASX Lunch Wrap: China-driven mining rally offset by tech slump on Nvidia probe
Broker Upgrades: Whole is greater than the sum, as Jarden urges buying into IDX-CAJ merger
ScoPo’s Powerplays: ASX health stocks rise as M&A activity heats up
MoneyTalks: Walk like an Egyptian, but Think like an Acquirer
SUNDAY ROAST: The stocks that lit a fire under our experts this week
MoneyTalks: The most irresistible ASX small cap takeover targets in 2024
ASX Health Stocks: Neuren up 17pc on DAYBUE sales, Argenica +40pc on Alzheimer’s data
10 at 11ish: MC Mining bounces on takeover bid, Block rockets
